Company Update (NYSE:MDT): Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill
January 28, 2015 at 06:01 AM EST
[at TheStreet] – Medtronic’s $49.9 billion acquisition of Covidien — the largest tax inversion deal ever — will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes. . . . → Read More: Company Update (NYSE:MDT): Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill Similar Articles: Market Update (NYSE:MDT): Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic Acquisition of Covidien Receives U.S. FTC Clearance Market Update: Medtronic Inc (NYSE:MDT) – Medtronic seeks EU approval for $43 bln Covidien deal
